About us
Team
Henrik Olsen
CEO
27 years of experience within the medical device industry with 19 years of experience in company or divisional management teams.
Previous assignments include CEO of Vigmed AB (publ), various positions at Coloplast A/S including Vice President positions within business development, marketing and sales, and Product Manager at Boston Scientific.
Sold Vigmed AB (publ) to an Austrian conglomerate.
Managed 60+ countries as VP of Sales in emerging markets at Coloplast.
Troels Johansen
CTO
Biomedical engineer and PhD specialized in the bioengineering and physiology of CO2 and oxygen.
Invented Rehaler’s technological concept and directed the further technical, clinical and scientific development.
During his Ph.D. at Aarhus University Hospital and Harvard Medical School he developed the world’s first method for 3D imaging of pulmonary gas transfer.
Previously served as Senior Teaching Fellow at the Biomedical Design Novo Nordisk innovation and entrepreneurship program.
_edited.jpg)
Sónia Maria Ferreira
Clinical Trial Manager
Biomedical engineer and PhD specialized in clinical trials, medical imaging and neuroscience.
Clinical Trial Manager of Rehaler's ongoing registration trial PAREMA1 (PArtial REbreathing for Migraine with Aura) with trial sites in Germany and the US, including Yale School of Medicine and Stanford University Clinic.
Henrik Stæhr-Olsen
CFO
CFO Henrik Stæhr-Olsen, is the former CFO at GIGA/Intel. Henrik has more than 30 years of experience from various enterprises as CFO.
Sónia Maria Ferreira
Clinical Trial Manager
Biomedical engineer and PhD specialized in clinical trials, medical imaging and neuroscience.
Clinical Trial Manager of Rehaler's ongoing registration trial PAREMA1 (PArtial REbreathing for Migraine with Aura) with trial sites in Germany and the US, including Yale School of Medicine and Stanford University Clinic.
Board of Directors
Thomas Feldthus
Chairman
Thomas Feldthus (M.Sc., MBA) is an experienced life science entrepreneur and executive.
Co-founder of Scandion Oncology A/S, Initiator Pharma A/S, Symphogen A/S, Saniona AB, Ataxion Inc and Leukotech A/S.
Bjørn Sperling (MD)
Highly experienced neurologist and clinical research leader.
VP Clinical Development, Head of Migraine & Pain Department, at Lundbeck A/S.
Helene Quie (M.Sc.)
Founder and CEO of Qmed Consulting A/S, a medtech CRO.
25+ years of experience within clinical and regulatory affairs, with focus on medtech.
Martin Møller (Mag.Art.)
Previously Senior Partner in McKinsey & Company.
20 years’ experience as strategy consultant within pharma and medtech.
Mette Gross (M.Sc.Econ.)
Experienced medtech CFO and chairwoman.
Current and previous assignments: Qlife, Iconovo AB, Vigmed, Coloplast, and others.
Eivind Johansen (M.Sc.Eng.)
Expert engineer (electronics, sensors and mechanics).
Co-founder and CTO of Giga A/S (acquired by Intel for 1.3B USD).
Co-founder of Rehaler.
Medical Advisory Board
Robert P. Cowan
Professor, MD
Director of Stanford University’s Headache Research Program (USA).
Founder of Keeler Center for the Study of Headache.
Pioneer in application of digital algorithms and machine learning to headache diagnostics.
Stewart J. Tepper
Professor, MD
Director of the Dartmouth Headache Clinic (USA)
Board member, American Headache Society.
Editor-in-Chief of the journal Headache Currents and Associate Editor for the journal Headache.
Dagny Holle-Lee
Professor, MD
Director of the West German Headache Center in Essen – a renowned center of excellence in headache treatment and research.
Author of more than 100 scientific articles as well as several scientific and popular science books.